Harmony’s CFO & The Art of Timely Disposals

A modest sum, perhaps, in the grand scheme of pharmaceutical fortunes. Though, as any seasoned investor knows, it’s not the size of the slice, but the quality of the pie. The weighted average purchase price, a mere $37.15 per share, suggests a degree of foresight. A man who buys low and sells… well, at a reasonable price, is a man to be reckoned with.






